一石二鸟：口服托法替布使一名斑块状银屑病患者的全秃症得到逆转。 - Suppr

Suppr

超能文献

Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis.

作者信息

Craiglow Brittany G, King Brett A

机构信息

Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA.

出版信息

J Invest Dermatol. 2014 Dec;134(12):2988-2990. doi: 10.1038/jid.2014.260. Epub 2014 Jun 18.

DOI:10.1038/jid.2014.260

PMID:24940651

Abstract

摘要

相似文献

Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis.

J Invest Dermatol. 2014 Dec;134(12):2988-2990. doi: 10.1038/jid.2014.260. Epub 2014 Jun 18.

Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman.

Acta Derm Venereol. 2017 Feb 8;97(2):283-284. doi: 10.2340/00015555-2491.

Excellent response to tofacitinib treatment in a patient with alopecia universalis.

Acta Dermatovenerol Alp Pannonica Adriat. 2017 Jun;26(2):47-49. doi: 10.15570/actaapa.2017.15.

Alopecia universalis. Partial response to tofacitinib.

Med Clin (Barc). 2019 Aug 2;153(3):e15. doi: 10.1016/j.medcli.2018.11.006. Epub 2019 Feb 1.

Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature.

Dermatol Online J. 2017 Jul 15;23(7):13030/qt224878kb.

A Case Report Highlighting the Effective Treatment of Alopecia Universalis With Tofacitinib in an Adolescent and Adult Patient.

J Cutan Med Surg. 2018 Jul/Aug;22(4):439-442. doi: 10.1177/1203475418760512. Epub 2018 Feb 20.

Reversal of Alopecia Universalis by Tofacitinib: A Case Report.

Ann Intern Med. 2016 Nov 15;165(10):750-751. doi: 10.7326/L16-0125.

Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis.

J Am Acad Dermatol. 2017 Apr;76(4):754-755. doi: 10.1016/j.jaad.2016.11.038.

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.

Lancet. 2015 Aug 8;386(9993):552-61. doi: 10.1016/S0140-6736(14)62113-9. Epub 2015 Jun 4.

XELJANZ (Tofacitinib) for Chronic Plaque Psoriasis.

Skinmed. 2015 May-Jun;13(3):227-9.

引用本文的文献

Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review.

Dermatol Ther (Heidelb). 2025 Aug 12. doi: 10.1007/s13555-025-01517-9.

The Current State of Patient Adherence to Lab Monitoring Guidelines for Janus Kinase Inhibitors in Patients with Alopecia Areata.

J Clin Aesthet Dermatol. 2025 Jun;18(6):26-28.

Evaluation of Olive Oil-Based Formulations Loaded with Baricitinib for Topical Treatment of Alopecia Areata.

Pharmaceutics. 2025 Apr 5;17(4):475. doi: 10.3390/pharmaceutics17040475.

Network Pharmacology and Experimental Validation Reveal Therapeutic Potential of Propolis in UV-Induced Allergic Dermatitis.

Foods. 2025 Mar 14;14(6):996. doi: 10.3390/foods14060996.

Efficacy and Safety of Tofacitinib in Lichen Planopilaris: A Retrospective Series of 74 Patients.

Arch Iran Med. 2025 Jan 1;28(1):24-28. doi: 10.34172/aim.33237.

Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023).

Dermatol Ther (Heidelb). 2023 Oct;13(10):2129-2151. doi: 10.1007/s13555-023-00991-3. Epub 2023 Aug 9.

Which is the Ideal JAK Inhibitor for Alopecia Areata - Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway.

Indian Dermatol Online J. 2023 Jun 28;14(4):465-474. doi: 10.4103/idoj.idoj_452_22. eCollection 2023 Jul-Aug.

Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways.

Int J Mol Sci. 2023 Jul 20;24(14):11711. doi: 10.3390/ijms241411711.

Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata.

Skin Health Dis. 2023 Jan 29;3(3):e209. doi: 10.1002/ski2.209. eCollection 2023 Jun.

JAK-STAT pathway inhibitors in dermatology.

An Bras Dermatol. 2023 Sep-Oct;98(5):656-677. doi: 10.1016/j.abd.2023.03.001. Epub 2023 May 23.

本文引用的文献

Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment.

Br J Dermatol. 2013 Nov;169(5):992-9. doi: 10.1111/bjd.12517.

A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis.

Br J Dermatol. 2013 Jul;169(1):137-45. doi: 10.1111/bjd.12266.

Tofacitinib (CP-690,550), an oral Janus kinase inhibitor, improves patient-reported outcomes in a phase 2b, randomized, double-blind, placebo-controlled study in patients with moderate-to-severe psoriasis.

J Eur Acad Dermatol Venereol. 2014 Feb;28(2):192-203. doi: 10.1111/jdv.12081. Epub 2013 Jan 7.

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study.

Br J Dermatol. 2012 Sep;167(3):668-77. doi: 10.1111/j.1365-2133.2012.11168.x.

Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550).

J Immunol. 2011 Apr 1;186(7):4234-43. doi: 10.4049/jimmunol.1003668. Epub 2011 Mar 7.

Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis.

J Invest Dermatol. 2009 Sep;129(9):2299-302. doi: 10.1038/jid.2009.25. Epub 2009 Feb 19.

Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs.

Immunol Rev. 2005 Feb;203:127-42. doi: 10.1111/j.0105-2896.2005.00220.x.

Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?

J Immunol. 2000 Aug 15;165(4):2240-50. doi: 10.4049/jimmunol.165.4.2240.

Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.

Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8705-9. doi: 10.1073/pnas.92.19.8705.

Treatment of alopecia areata by anthralin-induced dermatitis.

Arch Dermatol. 1979 Oct;115(10):1254-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验